NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES Toronto – September 30, 2019 (CNW) – Canada House Wellness Group (CSE: CHV) (“Canada House” or the “Company”) is pleased to report its financial results for the three months ending July 31, 2019. All amounts are stated in thousands of Canadian dollars.
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES Toronto – September 17, 2019 (CNW) – Canada House Wellness Group Inc. (CSE: CHV) (“Canada House” or the “Company”), announced today that the Company has closed its previously announced convertible security financing with the Lind Partners (“Lind”) for gross proceeds of $2,587,500
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES Toronto – September 10, 2019 (CNW) – Canada House Wellness Group Inc. (CSE: CHV) (“Canada House” or the “Company”), announced today that it has entered into a funding agreement (the “Funding Agreement” or “Agreement”) for the issue of convertible securities for gross
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES Toronto – September 3, 2019 (CNW) – Canada House Wellness Group Inc. (CSE: CHV) (“Canada House” or the “Company”), announced today that its wholly owned subsidiary, Abba Medix Corp. (“Abba”), has secured its amended sales license from Health Canada which allows for
Canada House Wellness Group is a leading cultivator of medical-grade, high-quality cannabis, and provider of cannabinoid therapy, targetting the medical & recreational markets globally.
